One of the most rampant diseases today is driven due to the fluctuation in the cholesterol levels. Know exactly what it is ...

The size and concentrations of lipoprotein particles were significantly associated with type 2 diabetes, independent of other risk factors, according to results of a long-term, prospective study ...

High cholesterol, known as the "silent killer," doesn't come with obvious symptoms and is usually only identified through a blood test.

Adults with type 1 diabetes may be more likely to ... vs. those with less than 10 nmol/L or what the researchers categorized as very low levels of lipoprotein(a) (RR = 1.51; 95% CI, 1.01-2.28 ...

The EPIC-Norfolk study is a population-based cohort study, described in detail previously. [18] This study recruited 25,639 men and women at baseline (1993–1997), aged 40–79 years living in ...

Lipoprotein particle measures may be more beneficial than standard cholesterol levels for characterizing ASCVD risk in metabolic syndrome, insulin resistance, and diabetes.

Eli Lilly on Sunday said the Phase 2 study of lepodisiran, designed to lower the production of lipoprotein(a), or lp(a), met its primary endpoint, reducing lp(a) levels by an average of 93.9% over ...